• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clonidine-induced increase in osmolar clearance and free water clearance via activation of two distinct alpha 2-adrenoceptor sites.可乐定通过激活两个不同的α2 -肾上腺素能受体位点诱导渗透清除率和自由水清除率增加。
Br J Pharmacol. 1996 Oct;119(4):663-70. doi: 10.1111/j.1476-5381.1996.tb15724.x.
2
Alpha-2a/d adrenoceptor subtype stimulation by guanfacine increases osmolar clearance.胍法辛对α-2a/d肾上腺素能受体亚型的刺激可增加渗透清除率。
J Pharmacol Exp Ther. 1997 Apr;281(1):48-53.
3
Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.莫索尼定刺激正常血压大鼠离体心脏释放心房利钠肽所涉及的受体。
Eur J Pharmacol. 2006 Jul 10;541(1-2):73-9. doi: 10.1016/j.ejphar.2006.05.009. Epub 2006 May 12.
4
A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.不同α2-肾上腺素能受体拮抗剂对可乐定中枢交感神经抑制作用的逆转的比较研究。
Br J Pharmacol. 1996 Feb;117(3):587-593. doi: 10.1111/j.1476-5381.1996.tb15231.x.
5
Role of alpha 2-adrenoceptors in the regulation of intestinal water transport.α2肾上腺素能受体在肠道水转运调节中的作用。
Br J Pharmacol. 1997 Mar;120(5):892-8. doi: 10.1038/sj.bjp.0700958.
6
Effects of the I(1) imidazoline/alpha(2)-adrenergic receptor agonist moxonidine in comparison with clonidine in the formalin test in rats.I(1)咪唑啉/α(2)-肾上腺素能受体激动剂莫索尼定与可乐定在大鼠福尔马林试验中的作用比较
Pain. 2000 Mar;85(1-2):161-7. doi: 10.1016/s0304-3959(99)00260-2.
7
Opposite rank order of potency for alpha-2 adrenoceptor agonists on water and solute excretion in the rat: two sites and/or receptors?α-2肾上腺素能受体激动剂对大鼠水和溶质排泄的效价顺序相反:两个位点和/或受体?
J Pharmacol Exp Ther. 1992 Jun;261(3):1080-6.
8
Potent alpha(2A)-adrenoceptor-mediated vasoconstriction by brimonidine in porcine ciliary arteries.溴莫尼定在猪睫状动脉中通过强效α(2A)-肾上腺素能受体介导的血管收缩作用。
Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2049-55.
9
Differential effects of alpha-adrenoceptor agonists on human retinal microvessel diameter.α-肾上腺素能受体激动剂对人视网膜微血管直径的不同影响。
J Ocul Pharmacol Ther. 2001 Jun;17(3):255-77. doi: 10.1089/108076801750295290.
10
Hypothalamic alpha 2A-adrenoceptors stimulate growth hormone release in the rat.
Eur J Pharmacol. 1995 Dec 4;287(1):43-8. doi: 10.1016/0014-2999(95)00472-9.

引用本文的文献

1
Antagonistic effects of atipamezole, yohimbine, and prazosin on xylazine-induced diuresis in clinically normal cats.阿替派唑、育亨宾和哌唑嗪对临床正常猫中赛拉嗪诱导利尿的拮抗作用。
Can J Vet Res. 2014 Oct;78(4):304-15.
2
Antagonistic effects of atipamezole, yohimbine and prazosin on medetomidine-induced diuresis in healthy cats.阿替美唑、育亨宾和哌唑嗪对健康猫中右美托咪定诱导利尿的拮抗作用。
J Vet Med Sci. 2014 Mar 1;76(2):173-82. doi: 10.1292/jvms.13-0398. Epub 2013 Oct 8.
3
High level of alpha2-adrenoceptor in rat foetal liver and placenta is due to alpha2B-subtype expression in haematopoietic cells of the erythrocyte lineage.大鼠胎儿肝脏和胎盘中高水平的α2-肾上腺素能受体是由于红细胞谱系造血细胞中α2B亚型的表达。
Br J Pharmacol. 2001 Aug;133(8):1387-95. doi: 10.1038/sj.bjp.0704203.

本文引用的文献

1
Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.莫索尼定是一种中枢性抗高血压药物,是I1-咪唑啉位点的选择性配体。
J Pharmacol Exp Ther. 1993 Jan;264(1):172-82.
2
Patterns of messenger RNA expression for adrenergic receptor subtypes in the rat kidney.
J Pharmacol Exp Ther. 1994 Mar;268(3):1605-11.
3
Renal imidazoline preferring sites and solute excretion in the rat.大鼠肾脏中咪唑啉优先结合位点与溶质排泄
Br J Pharmacol. 1993 Apr;108(4):870-5. doi: 10.1111/j.1476-5381.1993.tb13480.x.
4
Evidence for the existence of two forms of alpha 2A-adrenoceptors in the rat.大鼠体内存在两种α2A -肾上腺素能受体形式的证据。
Naunyn Schmiedebergs Arch Pharmacol. 1993 Mar;347(3):280-8. doi: 10.1007/BF00167446.
5
Alpha 2-adrenoceptors: more subtypes but fewer functional differences.α2肾上腺素能受体:亚型更多但功能差异更少。
Trends Pharmacol Sci. 1994 Apr;15(4):119-23. doi: 10.1016/0165-6147(94)90048-5.
6
Renal effects of the antihypertensive, guanabenz, in the dog.抗高血压药胍那苄对犬的肾脏影响。
J Pharmacol Exp Ther. 1982 May;221(2):347-52.
7
Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines.α肾上腺素能药物的中枢心血管效应:儿茶酚胺与咪唑啉类药物的差异
J Pharmacol Exp Ther. 1984 Jul;230(1):232-6.
8
Localization of alpha 2-adrenoceptor-mediated increase in renal Na+, K+, and water excretion.
Am J Physiol. 1987 Jun;252(6 Pt 2):F1016-21. doi: 10.1152/ajprenal.1987.252.6.F1016.
9
Heterogeneity of alpha-2 adrenergic receptors.α-2肾上腺素能受体的异质性
Pharmacol Biochem Behav. 1985 May;22(5):835-43. doi: 10.1016/0091-3057(85)90536-2.
10
Renal effects of selective alpha-1 and alpha-2 adrenoceptor agonists in conscious, normotensive rats.选择性α-1和α-2肾上腺素能受体激动剂对清醒正常血压大鼠的肾脏影响。
J Pharmacol Exp Ther. 1987 Mar;240(3):723-8.

可乐定通过激活两个不同的α2 -肾上腺素能受体位点诱导渗透清除率和自由水清除率增加。

Clonidine-induced increase in osmolar clearance and free water clearance via activation of two distinct alpha 2-adrenoceptor sites.

作者信息

Intengan H D, Smyth D D

机构信息

Department of Pharmacology & Therapeutics, University of Manitoba, Winnipeg, Canada.

出版信息

Br J Pharmacol. 1996 Oct;119(4):663-70. doi: 10.1111/j.1476-5381.1996.tb15724.x.

DOI:10.1111/j.1476-5381.1996.tb15724.x
PMID:8904639
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1915753/
Abstract
  1. Clonidine, an alpha 2-adrenoceptor agonist, will increase urine flow rate in the anaesthetized rat by increasing both free water and osmolar clearance. In the present study, we investigated whether these effects of clonidine were mediated at two sites which could be distinguished pharmacologically in uninephrectomized male Sprague-Dawley rats. 2. Clonidine (1.0 nmol kg-1 min-1) infused into the renal artery increased osmolar and free water clearance. Following pretreatment with prazosin (0.15 mg kg-1, i.v.), an antagonist with reported selectivity for the alpha 2b-adrenoceptor subtype, the increase in free water but not osmolar clearance was decreased. Pretreatment with the opioid receptor antagonist, naltrexone (3.0 mg kg-1, i.v.) attenuated the increase in osmolar but not free water clearance. This disparate antagonism of clonidine by prazosin and naltrexone was consistent with two distinct sites. 3. We submit the hypothesis that the alpha 2a- and alpha 2b-adrenoceptor subtypes mediated the clonidine-induced osmolar and free water clearance. The blockade in free water clearance by prazosin indicated a possible role of the alpha 2b-adrenoceptor subtype whereas the alpha 2a-adrenoceptor subtype was considered as the site mediating the clonidine-induced increase in osmolar clearance. UK-14,304 (1.0 nmol kg-1 min-1), a mixed alpha 2-adrenoceptor/imidazoline receptor agonist with selectivity for the alpha 2a-subtype increased only osmolar clearance. This increase was blocked by naltrexone but not prazosin pretreatment. The imidazoline receptor was not involved, as naltrexone failed to alter the moxonidine (3.0 nmol kg-1-min-1) induced increase in osmolar clearance. These data suggested to us that the alpha 2a-/alpha 26-subtype hypothesis should be investigated more closely in future studies. 4. These findings indicate that the increase in osmolar and free water clearance following clonidine can be distinguished pharmacologically indicating that two sites were involved. Furthermore, we propose the hypothesis that the alpha 2a-adrenoceptor subtype mediated osmolar clearance whereas the alpha 2b-subtype mediated free water clearance. The prazosin-sensitive increase in free water clearance following clonidine suggested a possible role for the alpha 2b-subtype. The naltrexone-sensitive increase in osmolar clearance following clonidine and UK-14,304 (but not moxonidine) suggested a possible role of the alpha 2a-subtype. Clearly, this postulate requires further study.
摘要
  1. 可乐定是一种α2肾上腺素能受体激动剂,通过增加自由水清除率和渗透清除率来提高麻醉大鼠的尿流率。在本研究中,我们探究了可乐定的这些作用是否在两个可通过药理学方法区分的部位介导,实验对象为单侧肾切除的雄性Sprague-Dawley大鼠。2. 经肾动脉输注可乐定(1.0 nmol·kg-1·min-1)可增加渗透清除率和自由水清除率。在用哌唑嗪(0.15 mg·kg-1,静脉注射)预处理后,哌唑嗪是一种据报道对α2b肾上腺素能受体亚型具有选择性的拮抗剂,自由水清除率的增加受到抑制,但渗透清除率不受影响。用阿片受体拮抗剂纳曲酮(3.0 mg·kg-1,静脉注射)预处理可减弱渗透清除率的增加,但不影响自由水清除率。哌唑嗪和纳曲酮对可乐定的这种不同拮抗作用与两个不同的部位一致。3. 我们提出假说,即α2a和α2b肾上腺素能受体亚型介导了可乐定诱导的渗透清除率和自由水清除率。哌唑嗪对自由水清除率的阻断表明α2b肾上腺素能受体亚型可能发挥作用,而α2a肾上腺素能受体亚型被认为是介导可乐定诱导的渗透清除率增加的部位。UK-14,304(1.0 nmol·kg-1·min-1)是一种对α2a亚型具有选择性的混合α2肾上腺素能受体/咪唑啉受体激动剂,仅增加渗透清除率。这种增加被纳曲酮预处理阻断,但未被哌唑嗪预处理阻断。由于纳曲酮未能改变莫索尼定(3.0 nmol·kg-1·min-1)诱导的渗透清除率增加,因此咪唑啉受体未参与其中。这些数据表明,在未来的研究中应更深入地研究α2a/α2b亚型假说。4. 这些发现表明,可乐定后渗透清除率和自由水清除率的增加可通过药理学方法区分,表明涉及两个部位。此外,我们提出假说,即α2a肾上腺素能受体亚型介导渗透清除率,而α2b亚型介导自由水清除率。可乐定后哌唑嗪敏感的自由水清除率增加表明α2b亚型可能发挥作用。可乐定和UK-14,304(但不是莫索尼定)后纳曲酮敏感的渗透清除率增加表明α2a亚型可能发挥作用。显然,这一假设需要进一步研究。